Rajasthan minister Babulal Kharadi has asked people to have more children, saying there should be no problem as Prime Minister Narendra Modi will build houses for them. Kharadi, the tribal area development minister in the desert state, said it is a dream of the prime minister that no one will go to sleep hungry and without a roof over their head. "It is a dream of the prime minister that no one should sleep hungry and without a roof over their head. You give birth to lots of children. Pradhan mantriji will build your houses, then what is the problem?" Kharadi asked while addressing a public meeting in Udaipur on Tuesday. Kharadi has eight children -- four sons and as many daughters -- from two wives. The entire family lives in Neechla Thala village, about three kilometres from Kotda tehsil of Udaipur. Chief Minister Bhajan Lal Sharma shared the dais with the tribal area development minister on the occasion. The stage was set up for a "Viksit Bharat Sankalp Yatra camp" in Udaipur's
The National Eligibility-cum-Entrance Test-Postgraduate examination has been rescheduled to July 7 this year, the National Board of Examinations in Medical Sciences said on Tuesday. The cut-off date for the purpose of eligibility for the exam this year is August 15. The exam was earlier scheduled to be held on March 3. "In supersession of NBEMS notice dated 09.11.2023 and pursuant to the receipt of NMC letter dated January 3, 2024, the conduct of NEET-PG 2024 examination, which was earlier notified to be tentatively held on March 3, 2024, stands rescheduled," the NBEMS said in a notice. "The NEET-PG 2024 shall now be conducted on July 7, 2024," it said. According to the recently notified "Post-Graduate Medical Education Regulations, 2023", the existing NEET-PG examination will continue till the proposed National Exit Test (NExT) becomes operational for the purpose of PG admission. The NEET-PG is an eligibility-cum-ranking examination prescribed as the single entrance examination
India has logged 475 new cases of Covid, while the number of active cases of the infection stood at 3,919, the health ministry said on Tuesday. Six deaths -- three from Karnataka, two from Chhattisgarh and one from Assam -- have been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, 2023 but cases began to increase after emergence of a new variant and cold weather conditions. After December 5, 841 new cases were reported on December 31, 2023 which was 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, a large majority of these (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," the sources stated. India has witnessed three waves of COVID-19 in the past
Nineteen persons have tested positive for JN.1 sub-variant of coronavirus in Mumbai, an official from the Brihanmumbai Municipal Corporation (BMC) said on Tuesday. Out of 22 samples found positive for JN.1 subvariant in Whole Genome Sequencing (WGS) analysis, 19 were from Mumbai, Daksha Shah, executive health officer of the BMC told PTI. Two samples belonged to patients from outside the city, and one was a duplicate, she said. According to a release issued by the civic body, these samples were sent for testing last month, and the reports arrived on Monday. All 19 patients who tested positive for JN.1 in the city suffered mild symptoms, and two of them had comorbidities. The patients have recovered from the infection, it stated. Most of the samples were tested at private laboratories, the release said. Of the 8,262 samples tested between December 1, 2023 and January 8, 2024, only 394 tested positive for coronavirus, it stated.
The number of cases of COVID-19 sub-variant JN.1 reported from 12 states till January 7 rose to 682, official sources said on Monday. They said 199 cases have been reported from Karnataka, 148 from Kerala, 139 from Maharashtra, 47 from Goa, 36 from Gujarat, 30 from Andhra Pradesh, 30 from Rajasthan, 26 from Tamil Nadu, 21 from Delhi, three from Odisha, two from Telangana and one from Haryana. Even though the number of cases is rising and the JN.1 sub-variant has been detected in the country, there is no cause of immediate concern as the majority of those infected are opting for home-based treatment, indicating mild illness, officials said. The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country. States have been urged to ensure effective compliance with the detailed operational guidelines for revised surveillance strategy for COVID-19 shared by the Union .
Analysts also feel this move will help improve quality of Indian drugs
New GMP guidelines set to elevate drug quality and industry compliance
The health ministry said in August that inspections of 162 drug factories since December 2022 found an 'absence of testing of incoming raw materials'
India has recorded a single-day rise of 774 COVID-19 cases while the number of active cases stands at 4,187, the Union health ministry said on Saturday. Two deaths -- one each from Tamil Nadu and Gujarat -- were reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases was in double digits till December 5 but it began to rise again amid cold weather conditions and after the emergence of a new COVID-19 variant, JN.1 After December 5, the highest single-day rise of 841 cases was reported on December 31, 2023, which was 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the 4,187 active cases, the majority (over 92 per cent) are recovering under home isolation. An official source said, "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality." India has witnessed three waves of COVID-19 in the pa
The number of cases of COVID-19 sub-variant JN.1 reported from 12 states till January 4 rose to 619, official sources said on Friday. They said 199 cases have been reported from Karnataka, 148 from Kerala, 110 from Maharashtra, 47 from Goa, 36 from Gujarat, 30 from Andhra Pradesh, 26 from Tamil Nadu, 15 from Delhi, 4 from Rajasthan 2 from Telangana and one each from Odisha and Haryana. Even though the number of cases is rising and the JN.1 sub-variant has been detected in the country, there is no cause of immediate concern as the majority of those infected are opting for home-based treatment, indicating mild illness, officials said. The Centre has already asked states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country. States have been told to ensure effective compliance of the detailed operational guidelines for revised surveillance strategy for COVID-19 shared by the Union Ministr
Earlier, Delhi LG VK Saxena recommended a CBI enquiry in the alleged 'Fake lab tests' in Aam Aadmi Mohalla clinics. Fake/non-existent mobile numbers were used to mark the entry of patients
The two cases were detected in Sundargarh and Bhubaneswar, Director of Health Services Bijay Kumar Mohapatra said, adding that the health conditions of both patients are stable
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging. In a communication to all states and UT drugs controllers cum licensing authorities, the Drugs Controller Genral of India (DCGI) stated that the decision was taken in view of the opinion that "blood is not for sale". Referring to the 62nd meeting of the Drugs Consultative Committee held on September 26, 2023, the DCGI in the letter on December 26 said, "It was recommended with respect of agenda No. 18 of ATR point 3, for overcharging of blood, it was opined that blood is not for sale, it is only for supply and only processing cost may be charged by the blood centre." The revised guidelines stipulate that only processing fees can be charged for blood or blood components which ranges between Rs 250 to 1,550 for blood or blood components. The DCGI has asked states and UT drug controllers to direct all blood
Covid-19 cases: Two deaths were reported in the past 24 hours. While active cases stood at 4,423, Karnataka reported the highest JN.1 variant cases at 199
The guidelines were compiled by a body of 24 experts having different levels of expertise in critical care medicine
Five deaths were reported due to Covid-19 in the past 24 hours. The uptick in the cases has been attributed to the emergence of the new 'JN. 1 variant' and cold weather conditions
These cases have been found across ten states and union territories, with Kerala reporting the maximum cases at 147. Goa (51 cases) and Gujarat (34 cases) followed Kerala
Since the Covid-19 outbreak in January 2020, the country has reported 45 million cases so far
A total of 196 cases of COVID-19 sub-variant JN.1 have been detected in the country so far, with Odisha joining the list of states that have detected the presence of the variant, according to the INSACOG's data updated on Monday. Ten states and Union territories have so far detected the presence of the JN.1 sub-variant of the virus. These states are Kerala (83), Goa (51), Gujarat (34), Karnataka (eight), Maharashtra (seven), Rajasthan (five), Tamil Nadu (four), Telangana (two) Odisha (one) and Delhi (one), according to the Indian SARS-CoV-2 Genomics Consortium (INSACOG). The INSACOG's data showed 179 Covid cases recorded in the country in December had the presence of JN.1, while 17 such cases were detected in November. The World Health Organisation (WHO) has classified JN.1 as a separate "variant of interest" given its rapidly-increasing spread, but said it poses a "low" global public health risk. The JN.1 sub-variant of the coronavirus was previously classified as a variant of ..
Maharashtra has recorded 137 Covid-19 deaths, with 70.80% occurring in individuals over 60 years of age